1. Home
  2. HYFT vs FORA Comparison

HYFT vs FORA Comparison

Compare HYFT & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HYFT

MindWalk Holdings Corp.

N/A

Current Price

$1.40

Market Cap

69.6M

Sector

Health Care

ML Signal

N/A

Logo Forian Inc.

FORA

Forian Inc.

N/A

Current Price

$2.10

Market Cap

66.2M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
HYFT
FORA
Founded
1983
2014
Country
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
69.6M
66.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HYFT
FORA
Price
$1.40
$2.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
422.4K
25.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$51.82
Revenue Next Year
$51.71
$7.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$1.64
52 Week High
$3.25
$4.03

Technical Indicators

Market Signals
Indicator
HYFT
FORA
Relative Strength Index (RSI) 35.27 45.96
Support Level $1.36 $2.07
Resistance Level $1.65 $2.10
Average True Range (ATR) 0.15 0.03
MACD -0.04 0.00
Stochastic Oscillator 6.90 35.71

Price Performance

Historical Comparison
HYFT
FORA

About HYFT MindWalk Holdings Corp.

MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

About FORA Forian Inc.

Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.

Share on Social Networks: